Gene Biotherapeutics, Inc.

CIK 772320 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Gene Biotherapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Oct 15, 2024REVOKED9999999997-24-004117
Feb 3, 2023SC 13G/A0001493152-23-003486
Apr 14, 202210-K/A0001493152-22-009863
Mar 30, 202210-K0001493152-22-008205
Jan 5, 2022SC 13G/A0001535610-22-000040
Oct 27, 202110-Q0001493152-21-026416
Sep 17, 202110-Q0001493152-21-023014
Sep 3, 202110-Q0001493152-21-021992
Aug 9, 20218-K/A0001493152-21-019050
Aug 5, 20218-K0001493152-21-018727
Jul 28, 20218-K0001493152-21-017997
Apr 28, 202140001493152-21-009928
Apr 28, 2021SC 13G0001493152-21-009930
Apr 26, 20218-K0001493152-21-009620
Apr 23, 202110-K0001493152-21-009535
Mar 18, 2021SC 13D/A0001493152-21-006313
Mar 18, 202140001493152-21-006314
Mar 1, 202130001493152-21-005114
Mar 1, 2021SC 13D0001493152-21-005117
Dec 22, 2020SC 13G0001062993-20-006522
Aug 17, 202030001493152-20-016065
Aug 14, 202030001493152-20-015752
Jul 8, 202030001493152-20-012829
Jul 8, 202030001493152-20-012831
Jun 1, 2020SC 13D0001493152-20-010298